Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA

Since the first case of COVID-19 was identified in the USA in January, 2020, over 46 million people in the country have tested positive for SARS-CoV-2 infection. Several COVID-19 vaccines have received emergency use authorisations from the US Food and Drug Administration, with the Pfizer–BioNTech va...

Descripción completa

Detalles Bibliográficos
Autores principales: Omer, Saad B, Benjamin, Regina M, Brewer, Noel T, Buttenheim, Alison M, Callaghan, Timothy, Caplan, Arthur, Carpiano, Richard M, Clinton, Chelsea, DiResta, Renee, Elharake, Jad A, Flowers, Lisa C, Galvani, Alison P, Lakshmanan, Rekha, Maldonado, Yvonne A, McFadden, SarahAnn M, Mello, Michelle M, Opel, Douglas J, Reiss, Dorit R, Salmon, Daniel A, Schwartz, Jason L, Sharfstein, Joshua M, Hotez, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592561/
https://www.ncbi.nlm.nih.gov/pubmed/34793741
http://dx.doi.org/10.1016/S0140-6736(21)02507-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592561/
https://www.ncbi.nlm.nih.gov/pubmed/34793741
http://dx.doi.org/10.1016/S0140-6736(21)02507-1

Ejemplares similares